**5.10 Biomarkers for risk assessment**

Bone markers have been shown to be useful for assessing the risk of developing osteonecrosis [47]. C-terminal telopeptide (CTX) and N-terminal telopeptide (NTX) are demonstrated as the two main bone markers that measure osteoclast activity, i.e., degradation of osteoclasts and osteoblasts [47].
